Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5047315 | 6213912 | I | 5047315-4 | 20060619 | 20060703 | EXP | 9039997-2006-00043 | DUSA PHARMACEUTICALS, INC. | N | 20060629 | OT | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5047315 | 1007453888 | PS | AMINOLEVULINIC ACID | 2 | 6%, 8%, OR 10%, ONCE, INSTI | D | D | 20965 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5047315 | 1007453888 | BLADDER CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5047315 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5047315 | URINARY TRACT INFECTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5047315 | CR |
| 5047315 | FGN |
| 5047315 | LIT |
| 5047315 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5047315 | 1007453888 | 4 | HR |